JW Lifescience Corporation (KRX:234080)
South Korea · Delayed Price · Currency is KRW 12,150
-370 (-2.96%)
At close: Aug 1, 2025, 3:30 PM KST
JW Lifescience Company Description
JW Lifescience Corporation provides national infusion solutions in South Korea and internationally.
The company offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions.
The company was formerly known as JW Co. Ltd. and changed its name to JW Lifescience Corporation in April 2011.
JW Lifescience Corporation was founded in 1994 and is based in Dangjin-si, South Korea.
JW Lifescience Corporation
| Country | South Korea |
| Founded | 1994 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 301 |
| CEO | Sungnam Cha |
Contact Details
Address: 28, Hanjin 1-gil Dangjin-si, 31720 South Korea | |
| Phone | 82 4 1351 7600 |
| Website | jw-lifescience.co.kr |
Stock Details
| Ticker Symbol | 234080 |
| Exchange | Korea Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7234080000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Sungnam Cha | Chief Executive Officer and Director |
| Jeong Yeol Noh | Executive Director and Head of HP Research Center |
| Na Sook Hee | Executive Director |